ReviewTherapeutic advances in medical oncology2024

Inhibition of the PI3K/AKT/mTOR pathway in pancreatic cancer: is it a worthwhile endeavor?

Al Jarroudi Ouissam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.